Ropacki, M., Gutierrez, S., Domilici, D., Lauterbach, E., Ferrer, M., Liebowitz, M., Donchev, T., Dutina, A., Brenner, R., Kozhuharov, H., Rosenberg, L., Ivkovic, M., Soefje, S., Grant, J., & Faller, D. (2023). Double-blind, randomised placebo-controlled, adaptive phase iib trial with vafidemstat in borderline personality disorder – aggregated baseline characteristics/demographics and safety. Neuroscience Applied, 2, 103854. https://doi.org/10.1016/j.nsa.2023.103854

van Hooijdonk, C. F. M., van der Pluijm, M., Smith, C., Yaqub, M., van Velden, F. H. P., Horga, G., Wengler, K., Hoven, M., van Holst, R. J., de Haan, L., Selten, J.-P., van Amelsvoort, T. A. M. J., Booij, J., & van de Giessen, E. (2023). Striatal dopamine synthesis capacity and neuromelanin in the substantia nigra: A multimodal imaging study in schizophrenia and healthy controls. Neuroscience Applied, 2, 101134. https://doi.org/10.1016/j.nsa.2023.101134

Zeni, C., Dedic, N., Jones, P., Wu, S., Anacker, C., Hajos-Korcsok, E., Synan, C., Milanovic, S., Hopkins, S., Bristow, L., & Koblan, K. (2022). Ulotaront improves metabolic parameters in rodent models of weight gain and hyperglycemia. Neuroscience Applied, 1, 100356. https://doi.org/10.1016/j.nsa.2022.100356